Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide
S. Srivastava, S. Verma, M. Kamthania, D. Agarwal, A. K. Saxena, M. Kolbe, S. Singh, A. Kotnis, B. Rathi, S. A. Nayar, H.-J. Shin, K. Vashisht, K. C. Pandey
This paper designs and validates Multi-Patch Vaccines against SARS-CoV-2 using a reverse epitomics approach, showing potential to cover a large ethnically diverse human population.
bioRxiv · Sep 6, 2020Immunology